Medical costs of keeping the US economy open during COVID-19

Jiangzhuo Chen, Anil Vullikanti, Stefan Hoops, Henning Mortveit, Bryan Lewis, Srinivasan Venkatramanan, Wen You, Stephen Eubank, Madhav Marathe, Chris Barrett, Achla Marathe

Abstract

We use an individual-based model and national-level epidemic simulations to estimate the medical costs of keeping the US economy open during the COVID-19 pandemic under different counterfactual scenarios. We model an unmitigated scenario and 12 mitigation scenarios which differ in compliance behavior to social distancing strategies and in the duration of the stay-home order. Under each scenario, we estimate the number of people who are likely to get infected and require medical attention, hospitalization, and ventilators. Given the per capita medical cost for each of these health states, we compute the total medical costs for each scenario and show the tradeoffs between deaths, costs, infections, compliance, and the duration of stay-home order. We also consider the hospital bed capacity of each Hospital Referral Region (HRR) in the US to estimate the deficit in beds each HRR will likely encounter given the demand for hospital beds. We consider a case where HRRs share hospital beds among the neighboring HRRs during a surge in demand beyond the available beds and the impact it has in controlling additional deaths.

Introduction

In 2020, policymakers faced a grueling dilemma: keep the economy closed to save lives or reopen to save livelihoods. However, "reopening" is not a cost-free endeavor; it carries massive medical expenses stemming from hospitalizations, ventilator use, and the "value of statistical life" lost to death. Simple epidemic models often fail to capture the nuances of human behavior and local infrastructure. This study addresses this gap by quantifying the direct medical trade-offs of 12 different mitigation scenarios, accounting for the duration of stay-home orders, compliance levels, and regional hospital resource sharing.

Methodology: Agent-Based Modeling and Disease Dynamics

The researchers employed a sophisticated Agent-Based Model (ABM) combined with a national-level epidemic simulation. Instead of treating the US as a single homogeneous group, they constructed a "synthetic" population based on US Census data and American Time Use Survey (ATUS) data, assigning individuals specific ages, households, and daily activity patterns (work, school, shopping).

The SEIR disease model tracks individuals through various health states, from exposure to recovery or death, which serves as the basis for medical cost estimation.

The disease progression was tracked using a Susceptible-Exposed-Infected-Recovered (SEIR) framework, stratified by age. To estimate costs, the researchers assigned dollar values to four specific health states based on Kaiser Family Foundation proxies: Medically Attended ($9,763), Hospitalized ($13,767), Ventilated ($61,168), and Death ($2 million, based on the "value of statistical life").

Results: The Power of Compliance and Duration

The study's findings highlight that human behavior—specifically compliance with social distancing—is a more critical factor than the absolute length of a lockdown.

  • The Cost of Inaction: An unmitigated scenario would have resulted in medical costs exceeding $1.1 trillion, roughly 5% of the US GDP.
  • The Compliance Gap: If compliance is high (90%), a 45-day lockdown is sufficient to effectively suppress the epidemic. However, if compliance drops to 60%, even a 60-day lockdown results in a massive second wave and costs hundreds of billions of dollars.
  • Best Case Savings: With 90% compliance and a 45-day lockdown, medical costs could be reduced to $35 billion—a 96% reduction compared to the unmitigated case.
Simulation results for 90% compliance show that extending stay-home duration significantly flattens the curve, drastically reducing the medical burden.

Furthermore, the research demonstrated that hospital bed sharing between Hospital Referral Regions (HRRs) is a vital strategy. When regions cooperate during surges, additional deaths due to bed shortages drop to nearly zero. Without such sharing, medical costs skyrocket as preventable deaths occur due to localized healthcare system fragility.

Discussion and Limitations

While the study provides a rigorous quantitative framework, the authors acknowledge that these estimates are likely conservative. The model used pneumonia treatment costs as a proxy; COVID-specific treatments like Remdesivir or long-term ICU stays may be significantly more expensive. Additionally, the scope is limited to direct medical costs and does not account for broader economic impacts such as lost productivity, supply chain disruptions, or the long-term healthcare burden of "Long COVID."

Future research should incorporate the costs of testing, tracing, and vaccine rollout to provide an even more comprehensive economic picture of pandemic management.

Summary updated

Abstract

We use an individual based model and national level epidemic simulations to estimate the medical costs of keeping the US economy open during COVID-19 pandemic under different counterfactual scenarios. We model an unmitigated scenario and 12 mitigation scenarios which differ in compliance behavior to social distancing strategies and in the duration of the stay-home order. Under each scenario we estimate the number of people who are likely to get infected and require medical attention, hospitalization, and ventilators. Given the per capita medical cost for each of these health states, we compute the total medical costs for each scenario and show the tradeoffs between deaths, costs, infections, compliance and the duration of stay-home order. We also consider the hospital bed capacity of each Hospital Referral Region (HRR) in the US to estimate the deficit in beds each HRR will likely encounter given the demand for hospital beds. We consider a case where HRRs share hospital beds among the neighboring HRRs during a surge in demand beyond the available beds and the impact it has in controlling additional deaths.
BibTeX
@inproceedings{chen2020medical,
  author = {Jiangzhuo Chen and Anil Vullikanti and Stefan Hoops and Henning Mortveit and Bryan Lewis and Srinivasan Venkatramanan and Wen You and Stephen Eubank and Madhav Marathe and Chris Barrett and Achla Marathe},
  title = {{Medical costs of keeping the US economy open during COVID-19}},
  booktitle = {Scientific},
  year = {2020},
  doi = {10.1038/s41598-020-75280-6},
}
Figure